Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 1162

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 1162
---
 future clinical studies could result in delays in any regulatory clearance or approval efforts and significantly
increase Renovaro Cube’s or BioSymetrics’ costs to recover or reproduce the data, and subsequently commercialize its future
products. If Renovaro Cube, BioSymetrics’ or either’s third-party collaborators, consultants, contractors, suppliers
or service providers were to suffer an attack or breach, for example, that resulted in the unauthorized access to or use or disclosure
of personal or health information, Renovaro Cube or BioSymetrics may have to notify physicians, patients, partners,

38

collaborators, government
authorities and the media, and may be subject to investigations, civil penalties, administrative and enforcement actions and litigation,
any of which could harm their business and reputation. Likewise, Renovaro Cube and BioSymetrics rely on third-party research institution
collaborators and other third parties to conduct clinical validation, and similar events relating to their computer systems could also
have a material adverse effect on Renovaro Cube’s or BioSymetrics’ business. To the extent that any disruption or security
breach were to result in a loss of, or damage to, Renovaro Cube’s or BioSymetrics’ data or systems, or inappropriate or unauthorized
access to or disclosure or use of confidential, proprietary, or other sensitive, personal, or health information, Renovaro Cube or BioSymetrics
could incur liability and suffer reputational harm, and the development and commercialization of its products could be delayed.

Renovaro
Cube’s or BioSymetrics’ insurance policies may not be adequate to compensate it for the potential losses arising from such
disruptions, failure, or security breach. In addition, such insurance may not be available to Renovaro Cube or BioSymetrics in the future
on economically reasonable terms, or at all. Further, Renovaro Cube’s or BioSymetrics’ insurance may not cover all claims
made against it and defending a suit, regardless of its merit, could be costly, divert management attention and harm Renovaro Cube’s
or BioSymetrics’ reputation.

If
Renovaro Cube or BioSymetrics is unable to protect the confidentiality of its trade secrets, Renovaro Cube’s or BioSymetrics’
business and competitive position would be harmed.

Renovaro
Cube and BioSymetrics rely on trade secrets and confidentiality agreements to protect their know-how, technology, data and other
proprietary information and to